Join Drs Benjamin Schlechter and Martin Dib as they discuss cutting-edge transplant techniques to treat colorectal cancer.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1000094. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Colorectal Cancer: Prevention, Diagnosis, and Therapeutic Options https://reference.medscape.com/slideshow/colorectal-cancer-6007241

Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients With Cirrhosis https://pubmed.ncbi.nlm.nih.gov/8594428/

Chemotherapy and Liver Transplantation Versus Chemotherapy Alone in Patients With Definitively Unresectable Colorectal Liver Metastases: A Prospective Multicentric Randomized Trial (TRANSMET) https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.3500

Safety and Feasibility of Chemotherapy Followed by Liver Transplantation for Patients With Definitely Unresectable Colorectal Liver Metastases: Insights From the TransMet Randomised Clinical Trial https://pubmed.ncbi.nlm.nih.gov/38721015/

Liver Transplantation for Hepatic Metastases From Colorectal Cancer: Current Knowledge and Open Issues https://pubmed.ncbi.nlm.nih.gov/36672295/

Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer https://pubmed.ncbi.nlm.nih.gov/23360920/

Survival Following Liver Transplantation for Patients With Nonresectable Liver-Only Colorectal Metastases https://pubmed.ncbi.nlm.nih.gov/31188200/

Carcinoembryonic Antigen https://www.ncbi.nlm.nih.gov/books/NBK578172/

BRAF Mutations in Colorectal Liver Metastases: Prognostic Implications and Potential Therapeutic Strategies https://pubmed.ncbi.nlm.nih.gov/36077604/

Perioperative Management of the Patient With Liver Disease https://emedicine.medscape.com/article/284667-overview

KRAS Mutations in Solid Tumors: Characteristics, Current Therapeutic Strategy, and Potential Treatment Exploration https://pubmed.ncbi.nlm.nih.gov/36675641/

R0 Liver Resection Should Be a First-Line Treatment for Selected Patients With Intermediate Hepatocellular Cancer https://pubmed.ncbi.nlm.nih.gov/37408800/